immunoglobulin G, human 20 % in 50 ML Injection

RxCUI: 1809061
RxNorm name: immunoglobulin G, human 20 % in 50 ML Injection
Display name: immunoglobulin G, human 20 % in 50 ML Injection
Full name: immunoglobulin G, human 20 % in 50 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125350	Hizentra	Immune Globulin Subcutaneous (Human), 20% Liquid	351(a)	Rx	2026-06-01
125596	Cuvitru	Immune Globulin Subcutaneous (Human), 20% Solution	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7b58f5ff-0316-49a3-b585-1f6003ddb953	immunoglobulin G, human 20 % in 50 ML Injection	PSN	26	These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 2010	20230420
7b58f5ff-0316-49a3-b585-1f6003ddb953	immunoglobulin G, human 10 GM per 50 ML Injection	SY	26	These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 2010	20230420
7b58f5ff-0316-49a3-b585-1f6003ddb953	50 ML immunoglobulin G, human 200 MG/ML Injection	SCD	26	These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 2010	20230420
7b58f5ff-0316-49a3-b585-1f6003ddb953	immunoglobulin G, human 20 % per 50 ML Injection	SY	26	These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 2010	20230420
9aad7ec9-6097-4805-8f1b-898bec35f218	50 ML immunoglobulin G, human 200 MG/ML Injection	SCD	19	These highlights do not include all the information needed to use CUVITRU ® safely and effectively. See full prescribing information for CUVITRU. CUVITRU ® , Immune Globulin Subcutaneous (Human), 20% Solution Initial U.S. Approval: 2016	20251125
9aad7ec9-6097-4805-8f1b-898bec35f218	immunoglobulin G, human 20 % in 50 ML Injection	PSN	19	These highlights do not include all the information needed to use CUVITRU ® safely and effectively. See full prescribing information for CUVITRU. CUVITRU ® , Immune Globulin Subcutaneous (Human), 20% Solution Initial U.S. Approval: 2016	20251125
9aad7ec9-6097-4805-8f1b-898bec35f218	immunoglobulin G, human 20 % per 50 ML Injection	SY	19	These highlights do not include all the information needed to use CUVITRU ® safely and effectively. See full prescribing information for CUVITRU. CUVITRU ® , Immune Globulin Subcutaneous (Human), 20% Solution Initial U.S. Approval: 2016	20251125
9aad7ec9-6097-4805-8f1b-898bec35f218	immunoglobulin G, human 10 GM per 50 ML Injection	SY	19	These highlights do not include all the information needed to use CUVITRU ® safely and effectively. See full prescribing information for CUVITRU. CUVITRU ® , Immune Globulin Subcutaneous (Human), 20% Solution Initial U.S. Approval: 2016	20251125